RV
RVL Pharmaceuticals plc
RVLPQ · OTC
$0.00 +0.00% (+$0.00)
Market Cap $1.11K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.00x
P/B 0.00x
P/E N/A
Growth
0 /100
Declining Rev. growth 40.83%
Book val. growth 23.63%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 80.98%
FCF margin 77.56%
Net margin 103.96%
Quality
7 /100
Poor ROIC 41.26%
Asset turnover 0.39x
ROA 40.22%
Debt
64 /100
Moderate Debt/Equity 1.13x
Net debt/EBITDA -0.36x
Current ratio 2.89x
Stability
22 /100
Unstable Beta 8.91x
Profitable years 0
Rev. volatility 144.80%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre RVLPQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Brian A. Markison
Employees
125
Headquarters
Bridgewater
Evenimente viitoare
13 NOV.
Earnings
Upcoming earnings report